8.47
0.11 (1.32%)
| Penutupan Terdahulu | 8.36 |
| Buka | 8.37 |
| Jumlah Dagangan | 2,651,351 |
| Purata Dagangan (3B) | 2,694,545 |
| Modal Pasaran | 1,854,594,176 |
| Harga / Jualan (P/S) | 33.26 |
| Harga / Buku (P/B) | 3.24 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2026 |
| Margin Operasi (TTM) | -597.47% |
| EPS Cair (TTM) | -1.11 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -27.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 28.66% |
| Nisbah Semasa (MRQ) | 10.22 |
| Aliran Tunai Operasi (OCF TTM) | -145.46 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -87.96 M |
| Pulangan Atas Aset (ROA TTM) | -27.21% |
| Pulangan Atas Ekuiti (ROE TTM) | -57.19% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Ocular Therapeutix, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.00 |
|
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.82% |
| % Dimiliki oleh Institusi | 87.01% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |